GLUD1 and neoplasm: The authors also found that an inhibitor of GDH1 (namely R162; 2-allyl-1-hydroxy-9,10-anthaquinone; 1-hydroxy-2-(2-propen-1-yl)- 9,10-anthracenedione) attenuated cancer cell proliferation and tumor growth in a number of human cancer cell lines but not in control cell lines [138].